Active
    Mainboard

    Sudeep Pharma Ltd

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    Sudeep Pharma Ltd IPO opened on 21 Nov 2025 and closed on 25 Nov 2025, with a price band of ₹563–₹593 per share. The IPO had a lot size of 25 shares, requiring a minimum investment of ₹14,825 per lot at the upper price band. The issue size was ₹895 crore, and the shares get listed on 28 Nov 2025.

    Sudeep Pharma Ltd IPO Details

    Listing Date

    28 Nov 2025

    Bid Price

    ₹563 - ₹593

    Lot Size

    25 Shares

    Minimum Investment

    ₹14,825 / Lot

    Issue Size

    ₹895 Cr

    Key Dates to Track

        Here are the important dates you need to know in order to participate in this IPO

    tick

    Offer Start Date

    21st Nov

    tick

    Offer End Date

    25th Nov

    tick

    Allotment Date

    26th Nov

    tick

    Refund Initiation

    27th Nov

    tick

    Demat Transfer

    27th Nov

    tick

    Listing Date

    28th Nov

    About Sudeep Pharma Ltd IPO

    Sudeep Pharma Ltd, founded in 1989, is seeking to raise about ₹95 crore through a fresh issue in its IPO, alongside a promoter-led offer-for-sale of roughly 1,00,76,492 shares. The company intends to deploy approximately ₹75.81 crore of the fresh proceeds toward capital expenditure, particularly for machinery procurement at its Nandesari facility. At the same time, the rest is earmarked for general corporate purposes.
     

    On the business side, Sudeep Pharma is a manufacturer of excipients and speciality mineral-based ingredients for the pharmaceutical, food, and nutrition sectors. It operates three manufacturing facilities in Vadodara, Gujarat, with a combined capacity of 65,579 metric tonnes as of 31 December 2024. The company has a global presence, supplying customers in over 100 countries. Its financials for the nine months ended 31 December 2024 show a revenue of ₹344.45 crore and a profit after tax of ₹94.54 crore.

    Sudeep Pharma Ltd Shareholding Pattern

      Pre-Issue Post-Issue
    Promoter Group 89.37% 76.15%
    Public Group 10.63% 23.85%

    Sudeep Pharma Ltd IPO Reservation

    QIB Shares Offered 30,18,550 (20%)
    NII (HNI) Shares Offered 22,63,913 (15%)
    Retail Shares Offered 52,82,462 (35%)
    Anchor Investor Shares Offered 45,27,825 (30%)
    Total Shares Offered 1,50,92,750
    Total Shares With Anchor Investor 1,50,92,750

    Sudeep Pharma Ltd IPO Lot Size

    Application Lots Shares Amount
    Retail (Min) 1 25 ₹14,825
    Retail (Max) 13 325 ₹1,92,725
    S HNI (Min) 14 350 ₹2,07,550
    S HNI (Max) 67 1,675 ₹9,93,275
    B HNI (MIN) 68 1,700 ₹10,08,100

    Sudeep Pharma Ltd IPO registrar

    MUFG Intime India Pvt Ltd
    Phone Number +91 81 0811 4949
    Email Id sudeeppharma.ipo@in.mpms.mufg.com
    Website https://in.mpms.mufg.com

    Sudeep Pharma Ltd IPO Lead Manager

    1. ICICI Securities Limited

    2. IIFL Capital Services Limited

    Sudeep Pharma Ltd Financial Information

    March 31, 2026 March 31, 2025 March 31, 2024
    Net Worth ₹883.34 Cr ₹493.09 Cr ₹356.03 Cr
    Reserves and Surplus ₹872.04 Cr ₹481.11 Cr ₹354.62 Cr
    Total Borrowing ₹148.29 Cr ₹135.25 Cr ₹75.03 Cr

    Strength of Sudeep Pharma Ltd

    • Market leadership with a diversified product portfolio in a high barrier industry.
    • Distinguished global customer base with long-standing relationships with key customers.
    • Well-equipped and regulatory compliant Manufacturing Facilities.
    • Strong research and development capabilities.
    • Experienced Promoters and senior management team.

    Risks Involved

    • The company generates a significant portion of its revenues from a limited number of customers and the loss of such customers or a decline in demand from such customers could adversely affect the company's business, results of operations, financial condition, and cash flows.
    • The company generated 66.43%, 65.84%, 67.64% and 77.01% of its revenue from operations from the company's pharmaceutical, food and nutrition segment, in the three months ended June 30, 2025 and Fiscals 2025, 2024 and 2023, respectively. Any adverse developments affecting this segment may adversely affect its business, results of operations, financial condition, and cash flows.
    • The company's Manufacturing Facilities are subject to periodic inspections and audits by regulatory authorities and customers and any manufacturing or quality control problems may subject us to regulatory action, damage its eputation and have an adverse effect on its business and results of operations.
    • Three of the company's four Manufacturing Facilities and one of its two R&D facilities are concentrated in a single region and any adverse developments affecting this region could have an adverse effect on the company's business, results of operations, financial condition and cash flows.
    • Any disruption, slowdown or shutdown in the company's manufacturing or R&D operations could adversely affect its business, results of operations, financial condition and cash flows.
    • The company generates a substantial portion of its revenue from operations from the company's export sales (58.68%, 59.27%, 64.43% and 68.45% of its revenue from operations for the three months ended June 30, 2025 and Fiscals 2025, 2024 and 2023, respectively) and any adverse developments in such regions, including the imposition of tariffs or other anti-sourcing legislation, could adversely affect the company's business, results of operations, financial condition and cash flows.
    • If the company is unable to introduce new products in a timely manner or if the products the company commercialize do not perform as expected, the company's business, results of operations, financial condition and cash flows may be adversely affected.
    • The company has recently undertaken the NSS Acquisition and may undertake similar acquisitions, investments, joint ventures or other strategic alliances in the future, which if unsuccessful, may adversely affect its business, results of operations and financial condition.
    • Any delay, interruption or reduction in the supply of raw materials and equipment to manufacture the company's products may adversely affect its business, results of operations, financial condition and cash flows.
    • The company's past performance may not be indicative of its future growth. The company may not be successful in implementing and managing its expansion and growth strategy effectively. Further, the company intend to diversify into different businesses beyond the pharmaceutical sphere, and failures to successfully implement such business ventures can negatively impact the company's results of operations and financial condition.

    Invest in IPOs with ease

    Sign-in to invest with your demat account, or set up a new demat account for free

    Industry Outlook of Sudeep Pharma IPO

    • The Indian pharmaceutical-ingredients space is supported by growing demand for excipients and specialty minerals, especially calcium-based products.

    • Sudeep Pharma operates in both the pharmaceutical and nutrition verticals, tapping into cross-industry tailwinds.

    • The company has an established global footprint, supplying to over 100 countries, which aligns with rising export trends in pharma ingredients.

    • Its production capacity is relatively large (65,579 metric tonnes across three plants), positioning it to scale with demand.

    • Acquisition of a European premix business (Nutrition Supplies Services) could help broaden its reach into infant and clinical nutrition — markets projected to grow.

    • Quality certifications (e.g., European suitability for its calcium products) could provide regulatory edge in international markets.

    • The broader Indian pharma industry is projected to grow, driven by domestic demand, innovation, and increasing global relevance.


    Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your IPO allotment status for Sudeep Pharma IPO.

    Explore Other IPOs

    • Current IPOs
    • Upcoming IPOs
    • Closed IPOs
    • IPO Performance
    • All
    • MainBoard
    • SME
    CORE4 ENGINEERS LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    23rd Oct 2026 - 10th Oct 2026
    Price Range
    ₹88.0 - 93.0
    IPO Size
    ₹54,82,00,000
    • All
    • MainBoard
    • SME
    Bidding Period
    26th Oct 2026 - 10th Oct 2026
    Price Range
    ₹1585.0 - 1665.0
    IPO Size
    ₹12,00,00,00,000
    BLS Polymers Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    27th Oct 2026 - 10th Oct 2026
    Price Range
    ₹142.0 - 150.0
    IPO Size
    ₹2,55,00,00,128
    Bidding Period
    27th Oct 2026 - 10th Oct 2026
    Price Range
    ₹313.0 - 330.0
    IPO Size
    ₹6,67,53,00,352
    Wiscon Industries Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    27th Oct 2026 - 10th Oct 2026
    Price Range
    ₹194.0 - 204.0
    IPO Size
    ₹1,10,00,00,000
    Carver Roboweld Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    28th Oct 2026 - 10th Oct 2026
    Price Range
    ₹76.0 - 80.0
    IPO Size
    ₹28,29,00,000
    M K Sons Fine Jewels Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹153.0 - 162.0
    IPO Size
    ₹2,75,39,99,872
    Bidding Period
    29th Oct 2026 - 11th Nov 2026
    Price Range
    ₹78.0 - 82.0
    IPO Size
    ₹1,83,05,99,936
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Advanced SysTek Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Advanta Enterprises Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Agilus Diagnostics Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    AGS Health Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Airox Technologies Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    AITMC Ventures Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Ajay Poly Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Allchem Lifescience Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    NO ACTIVE IPO HERE
    • All
    • MainBoard
    • SME
    JIO PLATFORMS LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    21st Oct 2026 - 10th Oct 2026
    Price Range
    ₹1065.0 - 1119.0
    IPO Size
    ₹3,02,13,00,03,968
    PARAS HEALTHCARE LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    21st Oct 2026 - 10th Oct 2026
    Price Range
    ₹660.0 - 693.0
    IPO Size
    ₹14,49,99,99,744
    Bidding Period
    15th Oct 2026 - 10th Oct 2026
    Price Range
    ₹327.0 - 344.0
    IPO Size
    ₹4,75,48,00,128
    Bidding Period
    15th Oct 2026 - 10th Oct 2026
    Price Range
    ₹558.0 - 586.0
    IPO Size
    ₹25,33,80,99,712
    SHELLZ INDIA LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    15th Oct 2026 - 10th Oct 2026
    Price Range
    ₹170.0 - 179.0
    IPO Size
    ₹59,97,00,032
    TONBO IMAGING INDIA LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    15th Oct 2026 - 10th Oct 2026
    Price Range
    ₹665.0 - 700.0
    IPO Size
    ₹8,52,17,99,680
    Bidding Period
    15th Oct 2026 - 10th Oct 2026
    Price Range
    ₹143.0 - 151.0
    IPO Size
    ₹50,12,33,00,864
    FUSION CX LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    14th Oct 2026 - 10th Oct 2026
    Price Range
    ₹275.0 - 289.0
    IPO Size
    ₹7,02,00,00,256
    Bidding Period
    14th Oct 2026 - 10th Oct 2026
    Price Range
    ₹105.0 - 112.0
    IPO Size
    ₹1,16,04,99,968
    HD FIRE PROTECT LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    13th Oct 2026 - 10th Oct 2026
    Price Range
    ₹258.0 - 271.0
    IPO Size
    ₹7,12,12,99,968
    VAIBHAV VYAPAAR LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    13th Oct 2026 - 10th Oct 2026
    Price Range
    ₹51.0 - 54.0
    IPO Size
    ₹42,10,00,000
    Bidding Period
    5th Oct 2026 - 10th Oct 2026
    Price Range
    ₹77.0 - 82.0
    IPO Size
    ₹34,99,00,032
    PARAMOUNT SYNTEX LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    30th Sep 2026 - 10th Oct 2026
    Price Range
    ₹119.0 - 127.0
    IPO Size
    ₹81,79,00,032
    Bidding Period
    30th Sep 2026 - 10th Oct 2026
    Price Range
    ₹186.0 - 196.0
    IPO Size
    ₹1,21,68,99,968
    TNA SOLUTIONS LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    30th Sep 2026 - 10th Oct 2026
    Price Range
    ₹66.0 - 70.0
    IPO Size
    ₹37,86,00,000
    SHREE TNB POLYMERS LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    28th Sep 2026 - 10th Oct 2026
    Price Range
    ₹50.0 - 53.0
    IPO Size
    ₹31,80,00,000
    SJP ULTRASONICS LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    30th Sep 2026 - 10th Oct 2026
    Price Range
    ₹67.0 - 67.0
    IPO Size
    ₹23,45,00,000
    Bidding Period
    30th Sep 2026 - 10th Oct 2026
    Price Range
    ₹55.0 - 55.0
    IPO Size
    ₹21,78,00,000
    VISHAL NIRMITI LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    30th Sep 2026 - 10th Oct 2026
    Price Range
    ₹208.0 - 220.0
    IPO Size
    ₹1,78,00,00,000
    EVENTIONS LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    30th Sep 2026 - 10th Oct 2026
    Price Range
    ₹112.0 - 118.0
    IPO Size
    ₹38,12,00,000
    • All
    • MainBoard
    • SME
    Issue Prize
    1785.00
    Listing Day Close
    1818.00(1.85%)
    LAPL AUTOMOTIVE LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    94.00
    Listing Day Close
    128.29(36.17%)
    Issue Prize
    344.00
    Listing Day Close
    378.20(9.88%)
    Issue Prize
    586.00
    Listing Day Close
    576.35(-1.71%)
    SHELLZ INDIA LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    179.00
    Listing Day Close
    170.05(-5.03%)
    TONBO IMAGING INDIA LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    700.00
    Listing Day Close
    1133.65(62.00%)
    Issue Prize
    151.00
    Listing Day Close
    138.30(-8.61%)
    FUSION CX LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    289.00
    Listing Day Close
    289.75(0.35%)
    HD FIRE PROTECT LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    271.00
    Listing Day Close
    307.20(13.28%)
    Issue Prize
    112.00
    Listing Day Close
    113.70(1.79%)
    VAIBHAV VYAPAAR LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    54.00
    Listing Day Close
    53.05(-1.85%)
    Issue Prize
    82.00
    Listing Day Close
    76.00(-7.32%)
    PARAMOUNT SYNTEX LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    127.00
    Listing Day Close
    109.25(-14.17%)
    Issue Prize
    196.00
    Listing Day Close
    232.05(18.37%)
    TNA SOLUTIONS LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    70.00
    Listing Day Close
    58.80(-15.71%)
    SHREE TNB POLYMERS LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    53.00
    Listing Day Close
    57.00(7.55%)
    SJP ULTRASONICS LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    67.00
    Listing Day Close
    73.01(8.96%)
    Issue Prize
    55.00
    Listing Day Close
    99.18(80.00%)
    VISHAL NIRMITI LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    220.00
    Listing Day Close
    204.25(-7.27%)
    EVENTIONS LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    118.00
    Listing Day Close
    105.45(-11.02%)

    Frequently Asked Questions

    What is Sudeep Pharma Ltd IPO?

    Sudeep Pharma Ltd IPO is a Mainboard IPO of 1,50,92,750 equity shares of a face value of ₹1 aggregating up to ₹895 Crores. The issue is priced at ₹563 to ₹593 per share. The minimum order quantity is 25 Shares. The IPO opens on November 21, 2025, and closes on November 25, 2025. MUFG Intime India Pvt Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE,NSE.

    When Sudeep Pharma Ltd IPO will open?

    The Sudeep Pharma Ltd IPO opens on November 21, 2025 and closes on November 25, 2025.

    What is the lot size of Sudeep Pharma Ltd?

    Sudeep Pharma Ltd lot size is 25 shares, and the minimum amount required is ₹14,825.

    How to apply for Sudeep Pharma Ltd IPO?

    You can apply in Sudeep Pharma Ltd IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. To apply for an IPO:

    • Login to Bajaj Broking account App/Website & click on IPO
    • Enter the number of lots and price at which you wish to apply.
    • Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.
    • You will receive a mandate notification to block funds in your UPI app.
    • Approve the mandate request on your UPI and funds will be blocked.

    When is Sudeep Pharma Ltd IPO allotment?

    The finalization of Basis of Allotment for Sudeep Pharma Ltd IPO will be done on November 26, 2025, and the allotted shares will be credited to your demat account by November 27, 2025.

    When is Sudeep Pharma Ltd IPO listing date?

    The Sudeep Pharma Ltd listing date is November 28, 2025.

    Who is the registrar of Sudeep Pharma Ltd IPO?

    The registrar of Sudeep Pharma Ltd IPO is MUFG Intime India Pvt Ltd

    Which company is the book-running lead manager of the IPO?

    ICICI Securities Limited,IIFL Capital Services Limited will be the book-running lead manager of this IPO.

    What is the fresh issue of Sudeep Pharma Ltd IPO?

    The fresh issue size is ₹95 Crores equity shares.

    What minimum lot size can retail subscribers subscribe to Sudeep Pharma Ltd?

    Retail investors can subscribe to a minimum of one lot, 25 shares and ₹14,825 amount.

    How can I approve the UPI mandate request for Sudeep Pharma Ltd IPO?

    To apply for Sudeep Pharma Ltd IPO, you need to log in to your demat account to complete the bidding process. Then, approve the payment mandate on your UPI app.

    What is the price range of Sudeep Pharma Ltd?

    The price of each Sudeep Pharma Ltd share will be ranging in between ₹563 to ₹593 per share.

    What is the cut-off time for the UPI mandate for Sudeep Pharma Ltd IPO?

    The cut-off time for the UPI mandate confirmation is 5:00 PM, November 25, 2025.

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Access Research Backed Stock Recommendations

    +91

    |

    Open Your Free Demat Account

    Access Research Backed Stock Recommendations

    +91

    |